Alexander Visekruna

4.8k total citations · 1 hit paper
61 papers, 3.0k citations indexed

About

Alexander Visekruna is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Alexander Visekruna has authored 61 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 28 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Alexander Visekruna's work include Immune Cell Function and Interaction (16 papers), Gut microbiota and health (14 papers) and T-cell and B-cell Immunology (12 papers). Alexander Visekruna is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Gut microbiota and health (14 papers) and T-cell and B-cell Immunology (12 papers). Alexander Visekruna collaborates with scholars based in Germany, United States and Sweden. Alexander Visekruna's co-authors include Maik Luu, Ulrich Steinhoff, Magdalena Huber, Hans‐Willi Mittrücker, Sabine Pautz, Till Adhikary, Thorsten Joeris, Stefan H. E. Kaufmann, Niyati Vachharajani and Hanna Leister and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Alexander Visekruna

59 papers receiving 3.0k citations

Hit Papers

The short-chain fatty acid pentanoate suppresses autoimmu... 2019 2026 2021 2023 2019 100 200 300

Peers

Alexander Visekruna
Alexander Visekruna
Citations per year, relative to Alexander Visekruna Alexander Visekruna (= 1×) peers Xinyang Song

Countries citing papers authored by Alexander Visekruna

Since Specialization
Citations

This map shows the geographic impact of Alexander Visekruna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Visekruna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Visekruna more than expected).

Fields of papers citing papers by Alexander Visekruna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Visekruna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Visekruna. The network helps show where Alexander Visekruna may publish in the future.

Co-authorship network of co-authors of Alexander Visekruna

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Visekruna. A scholar is included among the top collaborators of Alexander Visekruna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Visekruna. Alexander Visekruna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luu, Maik, Burkhard Schütz, Matthias Lauth, & Alexander Visekruna. (2023). The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment. Cancers. 15(5). 1588–1588. 33 indexed citations
2.
Brichkina, Anna, Florian Finkernagel, Alexander Visekruna, et al.. (2023). Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment. NAR Cancer. 5(1). zcad007–zcad007. 2 indexed citations
3.
Leister, Hanna, Maik Luu, Hans‐Joachim Mollenkopf, et al.. (2021). Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment. Cancer Immunology Research. 9(6). 682–692. 20 indexed citations
4.
Visekruna, Alexander & Maik Luu. (2021). The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis. Frontiers in Cell and Developmental Biology. 9. 703218–703218. 102 indexed citations
5.
Luu, Maik, et al.. (2020). Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy. Frontiers in Immunology. 11. 1225–1225. 92 indexed citations
6.
Schuster, Marc, Carlos Plaza‐Sirvent, Alexander Visekruna, Jochen Huehn, & Ingo Schmitz. (2019). Generation of Foxp3+CD25− Regulatory T-Cell Precursors Requires c-Rel and IκBNS. Frontiers in Immunology. 10. 1583–1583. 22 indexed citations
7.
Finkernagel, Florian, Barbara Joos, Andrea Nist, et al.. (2018). Chromatin Binding of c-REL and p65 Is Not Limiting for Macrophage IL12B Transcription During Immediate Suppression by Ovarian Carcinoma Ascites. Frontiers in Immunology. 9. 1425–1425. 11 indexed citations
8.
Luu, Maik, et al.. (2018). Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Scientific Reports. 8(1). 14430–14430. 246 indexed citations
9.
Kespohl, Meike, Niyati Vachharajani, Maik Luu, et al.. (2017). The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4+ T Cells. Frontiers in Immunology. 8. 1036–1036. 227 indexed citations
10.
Hagner, Stefanie, Hartmann Raifer, Ayşe Kılıç, et al.. (2017). IL-17 and TNF-α Are Key Mediators of Moraxella catarrhalis Triggered Exacerbation of Allergic Airway Inflammation. Frontiers in Immunology. 8. 1562–1562. 67 indexed citations
11.
Visekruna, Alexander, Niyati Vachharajani, Hani Harb, et al.. (2014). Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis. Mucosal Immunology. 8(2). 307–315. 11 indexed citations
12.
Joeris, Thorsten, Nicole Schmidt, David Ermert, et al.. (2012). The Proteasome System in Infection: Impact of β5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes. PLoS ONE. 7(6). e39827–e39827. 21 indexed citations
13.
Huber, Magdalena, Sylvia Heink, Axel Pagenstecher, et al.. (2012). IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. Journal of Clinical Investigation. 123(1). 247–260. 190 indexed citations
14.
Lawrenz, Matthew B., Alexander Visekruna, Anja A. Kühl, et al.. (2011). Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?. Mucosal Immunology. 5(2). 129–139. 25 indexed citations
15.
Reinhard, Katharina, Magdalena Huber, Elfadil Abass, et al.. (2011). c‐Rel promotes type 1 and type 17 immune responses during Leishmania major infection. European Journal of Immunology. 41(5). 1388–1398. 20 indexed citations
16.
Drescher, Anja, et al.. (2010). NALP expression in Paneth cells provides a novel track in IBD signaling. Langenbeck s Archives of Surgery. 395(4). 351–357. 4 indexed citations
17.
Schmidt, Nicole, Ernesto J. González, Alexander Visekruna, et al.. (2010). Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut. 59(7). 896–906. 143 indexed citations
18.
Visekruna, Alexander, Sonja Dullat, Jörn Gröne, et al.. (2009). Expression of catalytic proteasome subunits in the gut of patients with Crohn’s disease. International Journal of Colorectal Disease. 24(10). 1133–1139. 35 indexed citations
19.
Joeris, Thorsten, Melanie Rieger, Alexander Visekruna, et al.. (2006). Immunoproteasomes Are Essential for Clearance of Listeria monocytogenes in Nonlymphoid Tissues but Not for Induction of Bacteria-Specific CD8+ T Cells. The Journal of Immunology. 177(9). 6238–6244. 44 indexed citations
20.
Visekruna, Alexander, Thorsten Joeris, Daniel Seidel, et al.. (2006). Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis. Journal of Clinical Investigation. 116(12). 3195–3203. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026